Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX7W7J
|
||||
| Drug Name |
7-(2-cyclohexylethyl)-6-((pyridin-2-yloxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile
|
||||
| Synonyms |
CHEMBL524016
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C21H23N5O
|
||||
| Canonical SMILES |
N#Cc1ncc2cc(COc3ccccn3)n(CCC4CCCCC4)c2n1
|
||||
| InChI |
InChI=1S/C21H23N5O/c22-13-19-24-14-17-12-18(15-27-20-8-4-5-10-23-20)26(21(17)25-19)11-9-16-6-2-1-3-7-16/h4-5,8,10,12,14,16H,1-3,6-7,9,11,15H2
|
||||
| InChIKey |
AQSMXTCYTUNCFB-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.